Story perspectives
Texas AG Paxton Moves to Block Kenvue's $398M Dividend
11/6/2025
49 5
1 of 1
Story summary
- Texas Attorney General Ken Paxton filed a motion to block Kenvue, the maker of Tylenol, from issuing a $398 million dividend scheduled for November 26.
- Paxton argues the dividend would hinder paying penalties from a lawsuit alleging deceptive marketing toward pregnant women linking Tylenol to autism and ADHD.
- Kenvue says it will pursue action against the theories and notes the suit follows federal guidance urging caution with Tylenol during pregnancy.
